Globus Medical Q4 net sales $274.5M (+9.8% YoY); full year exceeds $1B; guides 2023 sales $1.1B

GLOBUS MEDICAL INC

2022-FY EPS reported $1.85 revenue$1,022,843,000

Q4 GAAP diluted EPS $0.49, non-GAAP diluted EPS $0.59; net income $50.1M (+231% YoY).
Full year 2022 net sales $1,022.8M (+6.8% YoY); GAAP diluted EPS $1.85, non-GAAP $2.06.
Non-GAAP adjusted EBITDA Q4 $90.2M (32.8% of sales); full year $339.2M (33.2%).
2023 guidance: net sales ~$1.1B, non-GAAP diluted EPS $2.30.
Company remains debt-free; net cash from ops $178.5M, free cash flow $104.4M for full year.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

GLOBUS MEDICAL INC reported Full Year 2022 results: revenue $1,022.8 million, net income $190.2 million, EPS $1.85.

Period: Full Year 2022
Revenue: $1,022.8 million
Net income: $190.2 million
EPS: $1.85
Result: reported results

Exact text from the filing

Full Year 20 2 2 : · Worldwide net sales were $ 1,022.8 million , an increase of 6.8 % , or 8.2% on a constant currency basis · GAAP n et income for the year was $ 1 90.2 million · GAAP d iluted EPS was $ 1. 85 and n on-GAAP diluted EPS was $ 2.0 6 · Non-GAAP adjusted EBITDA was $ 33 9.2 million, or 3 3.2 % of net sales

View on SEC.gov

Browse all earnings releases →

GLOBUS MEDICAL INC filing history →

Source: SEC EDGAR

accession 0001562762-23-000046

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.